Stem Cell Society Assembles Medical Advisory Board

Prominent group of physicians and researchers to provide leadership and oversight.

PORTLAND, OREGON, MARCH 1, 2011 – The International Cellular Medicine Society (ICMS), an international nonprofit organization dedicated to patient safety, physician education, and peer oversight,  announced today the creation of a new Medical Advisory Board.  The Society has created this board to provide a leadership role in its continuous development of clinical guidelines, practice standards, and adjudication review for cell based medical therapies.

The newly formed ICMS Medical Advisory Board comprised of physicians from major academic institutions, hospitals and private practices from around the globe. “The goal of the Medical Board,” said David Audley, Executive Director of the ICMS, “Is to work to make certain that the guidelines and practice standards of the ICMS ensure patient safety through peer oversight and transparency.”

One of the most important functions of the Medical Advisory Board will be to oversee the Clinic Accreditation Process that the ICMS announced earlier this week. Members of the Medical Advisory Board will review the protocols and evaluate the patient outcome data from clinics seeking accreditation. “With the proliferation of clinics worldwide,” said Dr Keith March, MD, PhD, a member of the Medical Advisory Board and the Board of Directors of the ICMS, “The need to have strict standards and independent review of practices for stem cell clinics is critical.”

A detailed list of the members of the Medical Advisory Board can be found on the ICMS website.